These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13555201)

  • 1. [Differential characteristics of Hageman & P.T.A. factors; role of contact in the initial phase of coagulation].
    SOULIER JP; WARTELLE O; MENACHE D
    Rev Fr Etud Clin Biol; 1958 Mar; 3(3):263-7. PubMed ID: 13555201
    [No Abstract]   [Full Text] [Related]  

  • 2. ONE-STAGE ASSAY FOR HAGEMAN FACTOR (FACTOR XII). FURTHER STUDIES ON THE ROLE OF HAGEMAN FACTOR IN BLOOD COAGULATION.
    HAANEN C; SCHOENMAKERS JG
    Thromb Diath Haemorrh; 1963 Jul; 18():557-69. PubMed ID: 14072245
    [No Abstract]   [Full Text] [Related]  

  • 3. [New data on the Hageman and P.T.A. factors and on the "contact"].
    SOULIER JP; PROU-WARTELLE O
    Rev Fr Etud Clin Biol; 1959 Nov; 4():932-8. PubMed ID: 13833029
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation of intermediate product I in a purified system. The role of factor IX or its precursor and of a Hageman factor-PTA fraction.
    YIN ET; DUCKERT F
    Thromb Diath Haemorrh; 1961 Sep; 6():224-34. PubMed ID: 14009111
    [No Abstract]   [Full Text] [Related]  

  • 7. The recognition of Hageman deficiency in blood donors.
    MARSH WL; JENKINS WJ
    J Clin Pathol; 1961 Sep; 14(5):550-1. PubMed ID: 14470228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models of blood coagulation.
    Mann KG; Brummel-Ziedins K; Orfeo T; Butenas S
    Blood Cells Mol Dis; 2006; 36(2):108-17. PubMed ID: 16500122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hemoconcentration and blood coagulation responses to acute mental stress.
    Zgraggen L; Fischer JE; Mischler K; Preckel D; Kudielka BM; von Känel R
    Thromb Res; 2005; 115(3):175-83. PubMed ID: 15617739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of red blood cell concentration on the initiation time of blood coagulation: risk of thrombus formation by hemoconcentration.
    Sagesaka T
    Clin Hemorheol Microcirc; 2004; 31(4):243-9. PubMed ID: 15567893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glass effect and platelet activity in Hageman plasma.
    OLLENDORFF P
    Thromb Diath Haemorrh; 1961 Jul; 6():104-17. PubMed ID: 13730854
    [No Abstract]   [Full Text] [Related]  

  • 12. Hageman trait.
    RATNOFF OD
    Thromb Diath Haemorrh; 1960; 4(Suppl)():116-22. PubMed ID: 13739761
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood clotting activities of thrombolytic agents with special reference to a Hageman-like effect.
    IATRIDIS SG; WILSON EG; FERGUSON JH; RIERSON HA
    Thromb Diath Haemorrh; 1960 Oct; 5():50-60. PubMed ID: 13717314
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification of factor IX or its precursor isolation of a Hageman-PTA fraction.
    YIN ET; DUCKERT F
    Thromb Diath Haemorrh; 1961 Sep; 6():215-23. PubMed ID: 14009110
    [No Abstract]   [Full Text] [Related]  

  • 15. Procoagulant activity of surface-immobilized Hageman factor.
    Chatterjee K; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Nov; 27(33):5643-50. PubMed ID: 16905185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
    Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
    Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass.
    van den Goor JM; Nieuwland R; Rutten PM; Tijssen JG; Hau C; Sturk A; Eijsman L; de Mol BA
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1029-36. PubMed ID: 17350849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.